evidence: Based on the primary endpoint (all criteria fulfilled), the subjects cured were 60/106 (56.6%) and 48/92 (52.2%) in ivermectin and thiabendazole arm, respectively (p = 0.53)
intervention: Ivermectin
comparator: Thiabendazole
outcome: Negative culture after having had positve culture